Early versus periprocedural administration of abciximab for primary angioplasty: a pooled analysis of 6 studies

Jochen Gödicke; Marcus Flather; Marko Noc; Mariann Gyöngyösi; Hans-Richard Arntz; Lars Grip; Henrique Mesquita Gabriel; Kurt Huber; Fiona Nugara; Joachim Schröder; Leif Svensson; Duolao Wang; Simona Zorman; Gilles Montalescot

doi:10.1016/j.ahj.2005.07.026

Early versus periprocedural administration of abciximab for primary angioplasty: a pooled analysis of 6 studies

Jochen Gödicke, Marcus Flather, Marko Noc, Mariann Gyöngyösi, Hans-Richard Arntz, Lars Grip, Henrique Mesquita Gabriel, Kurt Huber, Fiona Nugara, Joachim Schröder, Leif Svensson, Duolao Wang, Simona Zorman, Gilles Montalescot

Research output: Contribution to journal › Article › peer-review

49 Citations (Scopus)

Abstract

The 2004 ACC/AHA guidelines on ST-elevation myocardial infarction state that it is reasonable to start treatment with abciximab as early as possible before primary percutaneous coronary intervention (PCI). We investigated the potential benefit of early use of abciximab by pooling data from all the available studies.

Original language	English
Pages (from-to)	1015
Journal	American Heart Journal
Volume	150
Issue number	5
DOIs	https://doi.org/10.1016/j.ahj.2005.07.026
Publication status	Published - Nov 2005

Keywords

Angioplasty, Balloon, Coronary
Antibodies, Monoclonal
Female
Humans
Immunoglobulin Fab Fragments
Male
Middle Aged
Time Factors

Access to Document

10.1016/j.ahj.2005.07.026

Cite this

Gödicke, J., Flather, M., Noc, M., Gyöngyösi, M., Arntz, H-R., Grip, L., Gabriel, H. M., Huber, K., Nugara, F., Schröder, J., Svensson, L., Wang, D., Zorman, S., & Montalescot, G. (2005). Early versus periprocedural administration of abciximab for primary angioplasty: a pooled analysis of 6 studies. American Heart Journal, 150(5), 1015. https://doi.org/10.1016/j.ahj.2005.07.026

Gödicke, Jochen ; Flather, Marcus ; Noc, Marko ; Gyöngyösi, Mariann ; Arntz, Hans-Richard ; Grip, Lars ; Gabriel, Henrique Mesquita ; Huber, Kurt ; Nugara, Fiona ; Schröder, Joachim ; Svensson, Leif ; Wang, Duolao ; Zorman, Simona ; Montalescot, Gilles. / Early versus periprocedural administration of abciximab for primary angioplasty : a pooled analysis of 6 studies. In: American Heart Journal. 2005 ; Vol. 150, No. 5. pp. 1015.

@article{c04c301e6472405da16f649cade28c0f,

title = "Early versus periprocedural administration of abciximab for primary angioplasty: a pooled analysis of 6 studies",

abstract = "The 2004 ACC/AHA guidelines on ST-elevation myocardial infarction state that it is reasonable to start treatment with abciximab as early as possible before primary percutaneous coronary intervention (PCI). We investigated the potential benefit of early use of abciximab by pooling data from all the available studies.",

keywords = "Angioplasty, Balloon, Coronary, Antibodies, Monoclonal, Female, Humans, Immunoglobulin Fab Fragments, Male, Middle Aged, Time Factors",

author = "Jochen G{\"o}dicke and Marcus Flather and Marko Noc and Mariann Gy{\"o}ngy{\"o}si and Hans-Richard Arntz and Lars Grip and Gabriel, {Henrique Mesquita} and Kurt Huber and Fiona Nugara and Joachim Schr{\"o}der and Leif Svensson and Duolao Wang and Simona Zorman and Gilles Montalescot",

year = "2005",

month = nov,

doi = "10.1016/j.ahj.2005.07.026",

language = "English",

volume = "150",

pages = "1015",

journal = "American Heart Journal",

issn = "0002-8703",

publisher = "Mosby Inc.",

number = "5",

}

Gödicke, J, Flather, M, Noc, M, Gyöngyösi, M, Arntz, H-R, Grip, L, Gabriel, HM, Huber, K, Nugara, F, Schröder, J, Svensson, L, Wang, D, Zorman, S & Montalescot, G 2005, 'Early versus periprocedural administration of abciximab for primary angioplasty: a pooled analysis of 6 studies', American Heart Journal, vol. 150, no. 5, pp. 1015. https://doi.org/10.1016/j.ahj.2005.07.026

Early versus periprocedural administration of abciximab for primary angioplasty : a pooled analysis of 6 studies. / Gödicke, Jochen; Flather, Marcus; Noc, Marko; Gyöngyösi, Mariann; Arntz, Hans-Richard; Grip, Lars; Gabriel, Henrique Mesquita; Huber, Kurt; Nugara, Fiona; Schröder, Joachim; Svensson, Leif; Wang, Duolao; Zorman, Simona; Montalescot, Gilles.

In: American Heart Journal, Vol. 150, No. 5, 11.2005, p. 1015.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - Early versus periprocedural administration of abciximab for primary angioplasty

T2 - a pooled analysis of 6 studies

AU - Gödicke, Jochen

AU - Flather, Marcus

AU - Noc, Marko

AU - Gyöngyösi, Mariann

AU - Arntz, Hans-Richard

AU - Grip, Lars

AU - Gabriel, Henrique Mesquita

AU - Huber, Kurt

AU - Nugara, Fiona

AU - Schröder, Joachim

AU - Svensson, Leif

AU - Wang, Duolao

AU - Zorman, Simona

AU - Montalescot, Gilles

PY - 2005/11

Y1 - 2005/11

N2 - The 2004 ACC/AHA guidelines on ST-elevation myocardial infarction state that it is reasonable to start treatment with abciximab as early as possible before primary percutaneous coronary intervention (PCI). We investigated the potential benefit of early use of abciximab by pooling data from all the available studies.

AB - The 2004 ACC/AHA guidelines on ST-elevation myocardial infarction state that it is reasonable to start treatment with abciximab as early as possible before primary percutaneous coronary intervention (PCI). We investigated the potential benefit of early use of abciximab by pooling data from all the available studies.

KW - Angioplasty, Balloon, Coronary

KW - Antibodies, Monoclonal

KW - Female

KW - Humans

KW - Immunoglobulin Fab Fragments

KW - Male

KW - Middle Aged

KW - Time Factors

U2 - 10.1016/j.ahj.2005.07.026

DO - 10.1016/j.ahj.2005.07.026

M3 - Article

C2 - 16290988

VL - 150

SP - 1015

JO - American Heart Journal

JF - American Heart Journal

SN - 0002-8703

IS - 5

ER -